Gotham Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Sell |
17,607
-16,467
| -48% | -$355K | ﹤0.01% | 1397 |
|
|
2025
Q1 | $566K | Sell |
34,074
-35,892
| -51% | -$596K | ﹤0.01% | 1198 |
|
|
2024
Q4 | $1.28M | Buy |
69,966
+34,240
| +96% | +$628K | 0.01% | 839 |
|
|
2024
Q3 | $549K | Buy |
35,726
+5,129
| +17% | +$78.9K | 0.01% | 1079 |
|
|
2024
Q2 | $497K | Buy |
+30,597
| New | +$497K | 0.01% | 1084 |
|
|
2020
Q2 | – | Sell |
-6,975
| Closed | -$295K | – | 1045 |
|
|
2020
Q1 | $295K | Sell |
6,975
-8,683
| -55% | -$367K | 0.01% | 843 |
|
|
2019
Q4 | $670K | Sell |
15,658
-12,364
| -44% | -$529K | 0.01% | 718 |
|
|
2019
Q3 | $1.01M | Buy |
+28,022
| New | +$1.01M | 0.02% | 592 |
|
|
2017
Q4 | – | Sell |
-38,843
| Closed | -$1.46M | – | 921 |
|
|
2017
Q3 | $1.46M | Buy |
+38,843
| New | +$1.46M | 0.02% | 559 |
|
|
2017
Q1 | – | Sell |
-25,682
| Closed | -$741K | – | 977 |
|
|
2016
Q4 | $741K | Buy |
+25,682
| New | +$741K | 0.01% | 675 |
|